COVIVIO (COV.PA)

FR0000064578 - REIT

55.15  -1.3 (-2.3%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
1.004B
2.02%		1.175B
16.94%		863.5M
-26.49%		664.88M
-23.00%
EBITDA
YoY % growth
734.75M
2.54%		831.823M
13.21%		860.556M
3.45%		577.78M
-32.86%
EBIT
YoY % growth
642.533M
3.53%		769.551M
19.77%		791M
2.79%		535.57M
-32.29%
Operating Margin
63.97%65.52%91.60%80.55%
EPS
YoY % growth
4.35
3.33%		4.58
5.29%		4.47
-2.40%		4.27
-4.52%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q2 / 25 Q4 / 25
EPS
Q2Q % growth		2.14
1.48%
Revenue
Q2Q % growth		616.08M
40.88%
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		457.57M
14.74%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 2.24
-5.08%		2.220.020.81%
Q4 2023
Q2Q % growth		 2.11
-4.52%		2.030.083.94%
Q2 2023
Q2Q % growth		 2.36
-0.42%		2.330.031.15%
Q4 2022
Q2Q % growth		 2.21
2.31%		2.24-0.03-1.44%
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 431.3M
1.20%		287.85M143.45M49.83%
Q4 2023
Q2Q % growth		 437.3M
-29.85%		%
Q2 2023
Q2Q % growth		 426.2M
-22.68%		%
Q4 2022
Q2Q % growth		 623.385M
14.33%		%
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 1.19%
RevenueN/A N/A -0.37% -0.23%